RUNX1 and colorectal carcinoma: In summary, we define that TF RUNX1 enhances PTGS2 expression by elevating transcription activation of the PTGS2 promoter via the 1086–1096 bp binding motif, and as a consequence, promotes CRC cell growth, migration and invasion.